Literature DB >> 9428343

Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia.

A Gratsa1, H K Rooprai, J P Rogers, K K Martin, G J Pilkington.   

Abstract

Studies of developing mammalian tissues have established that certain neural cell adhesion molecules (NCAMs) may be down-regulated during the migratory phase concurrent with an increase in levels of matrix metalloproteinases. In addition, there is evidence that simple gangliosides such as GD3 are transiently present on the surface of such migratory cells. Since migration, or motility, is a prerequisite for diffuse local invasion of brain by neoplastic cells, the expression of NCAM and GD3 on brain tumour cells was studied in order to establish their possible role in the invasive process. An astrocytoma parent cell line (IPSB-18) and two morphologically distinct, cloned cell lines (clone 1 and 12) derived from it, were used in in vitro motility assays using 8 microns porosity polycarbonate filters in "Transwell" modified Boyden chambers. Immunocytochemical staining with anti-NCAM monoclonal antibodies (UJ13A and ERIC-1) and with the anti-ganglioside monoclonal antibodies LB1 (which recognises GD3) and A2B5 (which recognises a range of simple gangliosides) showed that some cells in culture from the parent line were positive for either NCAM or GD3; clone 1 was NCAM positive but GD3 negative, while clone 12 was NCAM negative but ganglioside positive. Motility assays showed that although clone 12 migrated more efficiently than either clone 1 or the parent line, this was not statistically significant. Moreover, similar assays were conducted on two further sub populations of cells which were evolved from the immunomagnetic separation of the parent cell line, IPSB-18, according to NCAM expression (i.e. NCAM positive and NCAM negative). The results indicated that the NCAM negative cells migrated more efficiently than the NCAM positive cells, in a time-dependent manner, when incubated for 4, 12 and 18 hours in Boyden chambers. These findings suggest that during the migratory phase of brain tumour invasion, NCAM expression is down-regulated whereas ganglioside expression is up-regulated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428343

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

Review 1.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

2.  Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.

Authors:  Pedro Duenisch; Rupert Reichart; Ulrike Mueller; Michael Brodhun; Rolf Bjerkvig; Bernd Romeike; Jan Walter; Christian Herbold; Christian R A Regenbrecht; Rolf Kalff; Susanne A Kuhn
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-04       Impact factor: 4.553

Review 3.  Migration and invasion in brain neoplasms.

Authors:  A J Bolteus; M E Berens; G J Pilkington
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

4.  Upregulation of Neural Cell Adhesion Molecule 1 and Excessive Migration of Purkinje Cells in Cerebellar Cortex.

Authors:  Shahin Shabanipour; Xiaodan Jiao; Maryam Rahimi-Balaei; Mohamad Reza Aghanoori; Seung H Chung; Saeid Ghavami; G Giacomo Consalez; Hassan Marzban
Journal:  Front Neurosci       Date:  2022-01-21       Impact factor: 4.677

5.  Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid.

Authors:  Dina El Demellawy; Ahmed Nasr; Salem Alowami
Journal:  Diagn Pathol       Date:  2008-02-06       Impact factor: 2.644

Review 6.  Ganglioside GD3 synthase (GD3S), a novel cancer drug target.

Authors:  Jinyi Liu; Xiangjin Zheng; Xiaocong Pang; Li Li; Jinhua Wang; Cui Yang; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2018-07-25       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.